Latest Updates

This year’s Match Day results show encouraging news for radiation oncology, which saw a nearly 60% drop in unfilled positions from last year, according to data published Friday by the National Resident Matching Program (NRMP).

Healthcare construction has ramped up in states that repealed or narrowed certificate of need laws.

The pharma industry has been left reeling by the recent news of US government trade tariffs, with companies Eli Lilly (Indianapolis, IN, US), Pfizer (New York, NY, US) and Merck & Co (Kenilworth, NJ, US) boosting their US manufacturing presence to avoid a potential 25% tariff on imported pharma products.

Inside the nation’s largest health insurance companies, artificial intelligence is taking off like a rocket.

MONDAY, March 24, 2025 (HealthDay News) -- More smokers are getting CT screenings for lung cancer, thanks to guideline changes that included younger people and those who’ve smoked less, a new study says.

Gov. Glenn Youngkin vetoed legislation for the second year in a row that would have established a Prescription Drug Affordability Board (PDAB).

The America First Policy Institute — the think tank founded and staffed by Trump officials to advance his vision for the country — has written a new paper making the case against what it calls pharmaceutical "global freeloading" and outlining various policy measures to address it.

Mark Vieth was stunned when he saw the numbers. Vieth coordinates the Defense Health Research Consortium, which advocates for a Pentagon program that has long received about $1.5 billion a year in federal funds for medical research — nearly half of which typically goes toward cancer.

Senate Majority Leader John Thune (R-S.D.) has cautioned GOP colleagues that the Senate isn’t likely to pass President Trump’s border security, energy and tax agenda until July at the earliest, and some Republican senators are warning the bill could drag well into the fall.

Johnson & Johnson announced on Friday that it will invest $55 billion in U.S. manufacturing, research and development, and technology over the next four years.